Literature DB >> 7722516

7B2 is a specific intracellular binding protein of the prohormone convertase PC2.

S Benjannet1, D Savaria, M Chrétien, N G Seidah.   

Abstract

Biosynthetic pulse-chase analyses have previously demonstrated that the prohormone convertase PC2 is first synthesized as a precursor pro-PC2 and that zymogen activation to PC2 occurs following the slow exit of pro-PC2 from the endoplasmic reticulum (ER) and its concentration within the trans-Golgi network (TGN). The endocrine and neural protein 7B2 is first synthesized as a nonglycosylated precursor (pro-7B2), which is cleaved within the TGN by a furin-like ubiquitous convertase at the RRKRR155S site to generate 7B2. In this report, we demonstrate that within the ER, pro-7B2 binds pro-PC2 but not any of the other convertases furin, PC1, PACE4, or PC5. This specific binding is Ca2+ dependent and does not require an N-glycosylated pro-PC2. Mutagenesis of the RRKRRS sequence demonstrated that the intact hexapeptide is critical for this binding, because the latter was abolished by mutations of the RR152 and greatly diminished by mutations of either the R151 or S156 residues of pro-7B2. Once the complex is formed in the ER, it is then transported to the TGN where furin or a furin-like convertase cleaves both precursors, even when present as a complex. We also provide evidence that following zymogen cleavage, 7B2 remains bound to PC2, suggesting the presence of at least one other Ca(2+)-dependent binding site within the 7B2 sequence. Coexpression of 7B2 and PC2, although resulting in an elevation of the level of pro-PC2, did not eliminate the processing of pro-PC2 to PC2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722516     DOI: 10.1046/j.1471-4159.1995.64052303.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

1.  Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing.

Authors:  L D Fricker; A A McKinzie; J Sun; E Curran; Y Qian; L Yan; S D Patterson; P L Courchesne; B Richards; N Levin; N Mzhavia; L A Devi; J Douglass
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

Review 2.  Neuroendocrine secretory protein 7B2: structure, expression and functions.

Authors:  M Mbikay; N G Seidah; M Chrétien
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis.

Authors:  Michael Helwig; Sang-Nam Lee; Jae Ryoung Hwang; Akihiko Ozawa; Juan F Medrano; Iris Lindberg
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

4.  7B2 prevents unfolding and aggregation of prohormone convertase 2.

Authors:  Sang-Nam Lee; Iris Lindberg
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

5.  The integrity of the RRGDL sequence of the proprotein convertase PC1 is critical for its zymogen and C-terminal processing and for its cellular trafficking.

Authors:  J Lusson; S Benjannet; J Hamelin; D Savaria; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  Phosphorylation and Alternative Splicing of 7B2 Reduce Prohormone Convertase 2 Activation.

Authors:  Bruno Ramos-Molina; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2015-03-26

7.  Latent transforming growth factor beta-binding proteins-2 and -3 inhibit the proprotein convertase 5/6A.

Authors:  Xiaowei Sun; Rachid Essalmani; Delia Susan-Resiga; Annik Prat; Nabil G Seidah
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

8.  Differences in the autocatalytic cleavage of pro-PC2 and pro-PC3 can be attributed to sequences within the propeptide and Asp310 of pro-PC2.

Authors:  K Scougall; N A Taylor; J L Jermany; K Docherty; K I Shennan
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

9.  Internal cleavage of the inhibitory 7B2 carboxyl-terminal peptide by PC2: a potential mechanism for its inactivation.

Authors:  X Zhu; Y Rouille; N S Lamango; D F Steiner; I Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.

Authors:  Baozhi Yuan; Jian Q Feng; Stephen Bowman; Ying Liu; Robert D Blank; Iris Lindberg; Marc K Drezner
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.